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Thioredoxin (Trx) and glutathione (GSH) systems are considered to be
two major redox systems in animal cells. They are reduced by NADPH
via Trx reductase (TR) or oxidized GSH (GSSG) reductase and further
supply electrons for deoxyribonucleotide synthesis, antioxidant de-
fense, and redox regulation of signal transduction, transcription, cell
growth, and apoptosis. We cloned and characterized a pyridine
nucleotide disulfide oxidoreductase, Trx and GSSG reductase (TGR),
that exhibits specificity for both redox systems. This enzyme contains
a selenocysteine residue encoded by the TGA codon. TGR can reduce
Trx, GSSG, and a GSH-linked disulfide in in vitro assays. This unusual
substrate specificity is achieved by an evolutionary conserved fusion
of the TR and glutaredoxin domains. These observations, together
with the biochemical probing and molecular modeling of the TGR
structure, suggest a mechanism whereby the C-terminal selenotet-
rapeptide serves a role of a protein-linked GSSG and shuttles elec-
trons from the disulfide center within the TR domain to either the
glutaredoxin domain or Trx.
In animal cells, redox regulation of many cellular processes isprovided by thioredoxin (Trx) and glutathione (GSH; oxidized
form of GSH is GSSG) systems (1). NADPH supplies reducing
equivalents for these redox systems via pyridine nucleotide
disulfide oxidoreductases, which in turn shuttle electrons to
downstream proteins and compounds through reversible thiol
oxidoreduction. The Trx and GSH systems are involved in a
variety of redox-dependent pathways such as providing reducing
equivalents for ribonucleotide reductase (the first step in DNA
biosynthesis) and peptide methionine sulfoxide reductase, an
antioxidant defense and regulation of the cellular redox state
(1–3). In addition, the Trx and GSH systems regulate activities
of various transcription factors, kinases, and phosphatases, and
they were implicated in the redox control of cell growth and
death, transcription, cell signaling, and other processes (4, 5).
The animal Trx system is composed of (i) Trx reductase (TR),
which is a homodimer of ’56-kDa subunits and is a member of
a pyridine nucleotide disulfide oxidoreductase family; (ii) Trx,
which is a ’12-kDa thiolydisulfide oxidoreductase; and (iii) Trx
peroxidase composed of two ’25-kDa subunits. At least two
such Trx systems, cytosolic and mitochondrial, have been iden-
tified, and additional homologs of each of these proteins also
have been described (6, 7).
The GSH system consists of (i) another member of the
pyridine nucleotide disulfide oxidoreductase family, GSSG re-
ductase (GR), a homodimer of ’55-kDa subunits; (ii) a g-Glu-
Cys-Gly tripeptide, GSH; (iii) an ’11-kDa thiolydisulfide oxi-
doreductase, glutaredoxin (Grx); and (iv) a GSH peroxidase
(GPx). Although only one form of GR, GSH, and Grx are known
in animal cells, five GPxs have been identified. GPxs are either
’20-kDa monomers or homotetramers of ’23-kDa subunits
and have distinct properties with respect to substrate specificity
and tissue and organelle expression (8).
It is noteworthy that among the components of the Trx and
GSH systems, several enzymes contain selenocysteine (Sec)
residues that are essential for enzyme function. Thus, TR1 (also
known as cytosolic TR, TRa, and TrxR1) and TR3 (also known
as mitochondrial TR, TRb, and TrxR2) contain a C-terminal
penultimate Sec residue (9–12), and four GPxs contain Sec in
their N-terminal active centers (8). Sec residues are generally
more reactive and characterized by lower redox potentials than
Cys residues, and Sec residues are ionized at physiological pH,
whereas Cys residues are typically protonated (10).
In addition to TR1 and TR3, we recently identified a partial
cDNA sequence for human TR2 and isolated its mouse ortholog
(12). We now describe cloning of the mouse cDNA for this protein
(designated TGR for thioredoxin and glutathione reductase) and
demonstrate that this enzyme can reduce several components of the
Trx and GSH systems. This unusual substrate specificity of TGR is
achieved by a natural fusion of TR and Grx domains, which are
predicted to communicate through the movement of the C-terminal
GSH-like Sec-containing tetrapeptide.
Experimental Procedures
Cloning of Mouse Testes TGR. A mouse testis expressed sequence tag
(EST) sequence (GenBank accession no. AA492975) was identified
on the basis of its homology to mouse TRs. We determined the
nucleotide sequence of this EST that revealed an incomplete ORF
for a new protein. Using primers derived from this partial cDNA
sequence, 59-GTGAACGTAGGCTGTATTCCAA-39 and 59-
GTTGACATAGGTCACGCCTTT-39, a mouse testis cDNA li-
brary was screened by PCR, and identified clones were further
analyzed with respect to insert size by agarose gel electrophoresis
(Genome Systems, St. Louis). The longest cDNA identified by this
procedure was characterized by nucleotide sequencing.
Isolation of TGR and TR1. TGR was purified (’3,000-fold) by using
a modified procedure previously developed for the isolation of
TR1 (11). Wild-type mouse testes (Pel-Freez Biologicals) (30 g)
were homogenized in 5 vol of 25 mM TriszHCl, pH 7.8, con-
taining 1 mM EDTA, 1 mM PMSF, 5 mgyml aprotinin, 5 mgyml
leupeptin, and 5 mgyml pepstatin A. After centrifugation at
18,000 g for 40 min, the supernatant was applied onto a DEAE-
Sepharose column equilibrated in 25 mM TriszHCl, pH 7.8y1
mM EDTA (buffer A). A gradient of 0–0.5 M NaCl in buffer A
was applied, and TGR was detected in fractions from the column
by immunoblot assays with antibodies specific for a C-terminal
20-mer peptide of mouse TGR (12). The enzyme eluted at ’200
mM NaCl, before TR1, which also was assayed by immunoblot
assays (with antibodies specific for a C-terminal peptide of TR1;
ref. 12) and eluted at ’250 mM NaCl. Fractions containing TGR
were diluted by 2.5-fold in 25 mM TriszHCl, pH 7.5y1 mM EDTA
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: Trx, thioredoxin; GSH, glutathione; GSSG, oxidized GSH; TR, Trx reductase;
TGR, Trx and GSSG reductase; GR, GSSG reductase; Grx, glutaredoxin; GPx, GSH peroxidase;
Sec, selenocysteine; EST, expressed sequence tag; DTNB, 5,59-dithiobis(2-nitrobenzoic acid);
HED, b-hydroxyethyl disulfide; LDH, lipoamide dehydrogenase; MIR, mercuric ion reduc-
tase; GPx4, phospholipid hydroperoxide GSH peroxidase.
Data deposition: The sequence reported in this paper has been deposited in the GenBank
database (accession no. AF349659).
‡To whom reprint requests should be addressed. E-mail: vgladyshev1@unl.edu.
The publication costs of this article were defrayed in part by page charge payment. This
article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C.
§1734 solely to indicate this fact.
www.pnas.orgycgiydoiy10.1073ypnas.051454398 PNAS u March 27, 2001 u vol. 98 u no. 7 u 3673–3678
BI
O
CH
EM
IS
TR
Y
(buffer B) and applied onto an ADP-Sepharose column equil-
ibrated in buffer B. The column was sequentially washed with
buffer B, 200 mM NaCl in buffer B, and the enzyme was eluted
with 1 M NaCl in buffer B. The fractions containing TGR were
made in 0.8 M ammonium sulfate and applied onto a phenyl-
HPLC column (TosoHaas, Montgomeryville, PA) equilibrated
in 0.8 M ammonium sulfate in buffer B. A gradient of 0.8 M
ammonium sulfate in buffer B to buffer B was applied and TGR
was eluted at ’100 mM ammonium sulfate. Fractions containing
TGR were collected, concentrated, aliquoted, and stored at
280°C before use. TR1 was isolated (’2,000-fold) from wild-
type mouse livers (Pel-Freez Biologicals) (100 g) according to a
previously published procedure (11). TGR and TR1 were puri-
fied to homogeneity as assessed by immunoblot assays and
Coomassie blue staining of SDSyPAGE gels.
Enzyme Assays. TR activities of TR1 and TGR were assayed by
two methods: (i) NADPH-dependent reduction of 5,59-
dithiobis(2-nitrobenzoic acid) (DTNB) determined as the in-
crease in absorbance at 412 nm at 25°C (13) and (ii) NADPH-
dependent reduction of 0.5 mgyml insulin and 3 mM Escherichia
coli Trx determined as the decrease in absorbance at 340 nm at
25°C (13). In the TR assays, substrate concentrations were
0.002–0.06 mM NADPH, 0.069–0.69 mM Trx, and 0.00125–
0.425 mM DTNB. GSH reductase activity of TGR was assayed
as NADPH-dependent reduction of GSSG determined as the
decrease in absorbance at 340 nm at 25°C (14). To determine
kinetic parameters, substrate concentrations varied from 2.5 to
500 mM GSSG and from 2 to 40 mM NADPH. Grx activity was
determined by using 0.01–0.5 mM b-hydroxyethyl disulfide
(HED) as a substrate (15), and the activity was assayed as the
decrease of absorption at 340 nm at 25°C. Lineweaver–Burk
plots were used to determine apparent Km and kcat values (16).
Isolation of Subcellular Fractions. A 75Se-labeled mouse testis (0.2 g;
wild type; 7 months old) was homogenized in 5 vol of ice-cold 0.25
M sucrosey5 mM TriszHCl, pH 7.2y1 mM MgCl2y1 mM PMSFy5
mg/ml aprotininy5 mg/ml leupeptiny5 mg/ml pepstatin A. The
homogenized solution was separated in four steps as follows: (i) The
solution was settled by gravity for 20 min to remove unbroken cells.
(ii) The liquid fraction was removed and centrifuged at 1,000 g for
20 min. The pellet was considered as the nuclear fraction. (iii) The
remaining supernatant was centrifuged at 10,000 g for 20 min. The
pellet was considered as the mitochondrial fraction; and (iv) the
remaining supernatant was centrifuged at 105,000 g for 2 h. The
pellet was considered as the microsomal fraction and the superna-
tant as the cytosolic fraction. The nuclear, mitochondrial, and
microsomal fractions were washed in the homogenization buffer
and recentrifuged twice before use (17). Mouse tissues metaboli-
cally labeled with 75Se were obtained as described (18).
Gel Filtration. Mouse testes were homogenized and centrifuged to
remove nuclear and mitochondrial fractions as described above.
The supernatant containing microsomal and cytosolic fractions
(0.8 ml, 4 mg total protein) was applied onto a Superose 6
column (1 3 50 cm, ’40 ml) that had been equilibrated in 5 mM
TriszHCl, pH 7.5y0.25 M sucrosey0.1 M NaCly1 mM PMSF,
followed by elution of proteins in the same solution. TGR was
detected in the column fractions by using immunoblot assays. Kav
was calculated as Kav 5 (Velution 2 Vvoid)y(Vtotal 2 Vvoid), where
V is the volume, and compared with Kav of standards. The
standards used were aldolase (158 kDa), catalase (232 kDa),
ferritin (440 kDa), and thyroglobulin (669 kDa). Blue Dextran
2000 was used to determine the column void volume.
Immunoprecipitation. The rat testes microsomal fraction was soni-
cated in the solution containing 50 mM TriszHCl, 150 mM NaCl,
and 1% IGEPAL CA-630, pH 7.4 (immunoprecipitation buffer).
The sonicate was divided into five fractions each containing 500 mg
of protein, which were supplemented with either 100 mM H2O2, 5
mM DTT, 5 mM NADPH, 5 mM GSH, or water. Each fraction was
additionally supplemented with antibodies specific for TGR (4 mg),
and the resulting solutions (1 ml each) were rotated for 1.5 h at 4°C.
Subsequently, 100 ml of protein A Sepharose was added to each
tube and the samples were rotated for an additional hour at 4°C.
After a brief centrifugation, the supernatants were removed and
concentrated by using Microcon (Millipore) microconcentrators.
The pellets were washed four times with 1 ml of the ice-cold
immunoprecipitation buffer and used as immunoprecipitate. Both
types of samples were subjected to SDSyPAGE analysis under
denaturing conditions followed by immunoblot detection with
antibodies specific for TGR (19).
Molecular Modeling. The SYBYL 6.6 software package (Tripos
Associates, St. Louis) was used to build a molecular model of the
TGR homodimer. The homology modeling of the pyridine
nucleotide disulfide oxidoreductase and Grx portions of TGR
was performed separately by using the COMPOSER module of
SYBYL. The Grx domain was modeled starting with Gly-37.
Probable conformations of the nine-residue peptide that linked
the TR and Grx portions of TGR were determined by using
methods of secondary structure prediction as implemented in
SYBYL. The conformations were energy-minimized and visually
inspected to provide close proximity of the functionally impor-
tant residues. The homodimer was built from the monomeric
chains by superimposing the conservative residues of the active
site in the model and the used crystal or NMR structures by using
the FIT procedure. Energy refinement (500 iterations of energy
minimization) was performed with the Kollman all-atom force
field and the Kollman charges. The distance-dependent dielec-
tric model (with « equal to 4r) was used for electrostatic energy
calculations. The force field parameters and partial atomic
charges for the Sec residue were as in ref. 45. The PROTABLE
module of SYBYL was used to assess the quality of the structural
model. Approximately 99% of the modeled residues occupied
conformationally allowed regions of the Ramachandran plot.
Only three cis-peptide bonds were found in the model. Two of
them, Val-92–Pro-93 and His-588–Pro-589, were adopted from
the template molecules, 1JHB and 1FEC, respectively. The third
cis-peptide bond, Gly-612–Cys-613, was necessary to ensure a
low-energy conformation of selenosulfide bond formed by the
Cys-613–Sec-614 pair in the oxidized state.
Results and Discussion
Cloning and Structural Features of a Mouse Testis TGR. A partial
cDNA sequence for human TR2 has been identified (12). We
have now cloned mouse cDNA for this protein. The mouse
cDNA contained an ORF of 615 aa and was designated TGR.
The mouse TGR gene was organized in 16 exons and 15 introns
and located on chromosome 6 (GenBank accession number of
the bacterial artificial chromosome clone is AC051638) as evi-
denced by homology analyses using mouse TGR cDNA sequence
against sequences generated by the Mouse Genome Project.
Mouse TGR exhibited strong sequence homology to a partial
sequence of human TGR (formerly TR2, 88% identity), human
TR1 (73% identity), and human TR3 (56% identity) (Fig. 1A),
and it showed a more distant homology (20–35% identity) to
GR, lipoamide dehydrogenase (LDH), and mercuric ion reduc-
tase (MIR) from various sources. Like these homologous pyri-
dine nucleotide disulfide oxidoreductases, TGR contained se-
quences characteristic of NADPH- and FAD-binding domains,
a dimer interface domain, and a thiolydisulfide redox active
center (Fig. 1B).
In addition, the TGR contained a C-terminal extension that
terminated with Gly-Cys-Sec-Gly, a conserved tetrapeptide
3674 u www.pnas.orgycgiydoiy10.1073ypnas.051454398 Sun et al.
found in other animal TRs (Fig. 1 A and B). Sec was encoded by
an in-frame TGA codon, whereas the downstream stop signal
was TAG.
TGR also contained an N-terminal domain not present in
other pyridine nucleotide disulfide oxidoreductases (Fig. 1 A and
B). This domain exhibited strong homology to various Grxs and
had a characteristic GSH-binding motif. The fusion of TR and
Grx or any other two proteins or domains belonging to the Trx
and GSH systems had not been previously described. Interest-
ingly, the N-terminal domain of TGR had a single Cys in place
of the CxxC redox motif that is involved in a reversible disulfide
formation in glutaredoxins. However, a new eukaryotic Grx
subfamily was recently characterized, whose members had a
single Cys but maintained the Grx function (24). We also
detected partial sequences of zebrafish, Xenopus, and the trem-
atode Schistosoma mansoni TGRs, and these proteins contained
the CxxC motif within the Grx domain. However, human TGR,
like the mouse enzyme, had a single Cys (Fig. 1 A). The occur-
rence of TGR in several nonmammalian eukaryotes suggested
an evolutionary advantage of linking the TR and Grx domains.
TGR Exhibits Specificity for GSH and Trx Systems. To determine
whether TGR had a functional Grx domain, we first directly
purified this enzyme to homogeneity from mouse testes and
tested its binding to GSH-Sepharose, an affinity resin that had
been used previously for isolation of GSH-binding proteins. As
a control, we used mouse liver TR1 (11), which is the closest
homolog of TGR, but lacks the N-terminal Grx domain. The
binding studies demonstrated that TGR bound GSH-Sepharose,
whereas TR1 did not (Fig. 2A). In addition, we tested relevant
electron donors for their ability to reduce TR1 and TGR.
Reduction of enzymes was monitored by alkylation with 5-
iodoacetamido-fluorescein, the reagent that can covalently mod-
ify reactive thiols and selenols (25) including the Sec residue in
TR1 (12). The presence of fluorescein was then determined by
immunoblot assays with antif luorescein antibodies. We found
that NADPH reduced both TR1 and TGR. However, GSH only
reduced TGR (Fig. 2B). Thus, TGR exhibited affinity for GSH.
We further examined substrate specificity of TGR by charac-
terizing its reactions with various components of the Trx and
GSH systems and other substrates. Table 1 shows that TGR
catalyzed NADPH-dependent reductions of DTNB and Trx,
which are TR activities (13); NADPH-dependent reduction of
GSSG, which is GR activity (14); and NADPH-dependent
reduction of a mixed disulfide (b-mercaptoethanol-GSH mixed
disulfide) obtained by the reaction of GSH with HED, which is
Grx activity (15). In contrast, mouse liver TR1 was only active as
TR. Purified mouse testis TGR had lower TR-specific activities
than TR1, which could be due to the presence of significant
amounts of truncated or inactive forms of TGR in our enzyme
preparations. However, kinetic parameters (16) of TGR were
similar to those of TR1 for the reduction of Trx (Table 1). Km and
kcat of TGR for the reduction of GSSG and HED were somewhat
lower than the previously published values for GR and Grx, but
catalytic efficiencies of these enzymes could be compared with
that of TGR (26–30). Thus, TGR could functionally replace TR,
GR, and Grx in in vitro assays. In addition, the NADPH
dependence of catalytic activities (Table 1) suggested that the
TR and Grx domains of TGR communicated in a redox manner.
The fusion of Trx and TR domains was previously reported for
an enzyme from the bacterium Mycobacterium leprae (31), and
a similar fusion occurs in Arabidopsis thaliana sequences (data
not shown). The smaller plant, yeast, and bacterial TRs and
larger animal TRs evolved by convergent evolution and inde-
pendently acquired disulfide reduction function. The smaller
enzymes lack the Sec redox center and exhibit a different
reaction mechanism and three-dimensional structures compared
with animal TRs and homologous pyridine nucleotide disulfide
oxidoreductases (32–34). Although the fusion of the Trx and TR
domains in bacteria and plants generated enzymes that are
components of the same redox system (35), the fusion of the Grx
Fig. 1. Primary structures of TGR and homologous proteins. (A) Alignment of
mouse TGR with partial sequences of human (AF171055, EST), Schistosoma ja-
ponicum (AI133811, EST), zebrafish (AW280285, AW778593, and AW153764,
ESTs) and Xenopus (AW765014, EST) TGRs, and full-size sequences of human
(S47472) and E. coli (P00277) Grxs, human TR1 (S66677), and human TR3
(NP_006431). Conserved residues are shaded. Active site Cys residues (the CxxC
motif in the Grx domain, the disulfide center in the pyridine nucleotide disulfide
oxidoreductase domain, and the Cys in the C-terminal extension) are shown by
closed circles above sequences. The Sec residue (U) is indicated by an open circle
above sequences. Residues involved in binding of GSH are shown by closed
triangles above sequences. Grx, pyridine nucleotide disulfide oxidoreductase,
and C-terminal portions of enzymes are shown by arrows below sequences.
Mitochondrial signal peptide in TR3, cleaved in the mature protein, is shown in
italics. Residue numbers within the alignment are shown above sequences and
within individual sequences on the right. (B) Schematic representation of the
domain organization of TGR, TR1, TR3, GR, LDH, and MIR. These six proteins
possess active center disulfides (the CxxxxC motif; two cysteines separated by
fourother residues), FAD-andNADPH-bindingdomains,dimer interfacedomain,
and other features of the pyridine nucleotide disulfide oxidoreductase family.
TGR, TR1, and TR3 also contain an extension with a conserved C-terminal GCUG
(U is Sec) tetrapeptide sequence. This tetrapeptide may be viewed as functionally
analogous to two molecules of GSH (or to GSSG) in the GSH system. In addition,
TGR contains an N-terminal Grx domain, which is structurally and functionally
similar tothiolydisulfideoxidoreductases (Grx intheGSHsystemandTrx intheTrx
system). These proteins are substrates for pyridine nucleotide disulfide oxi-
doreductases and contain an active site CxxC motif (two cysteines separated by
two other residues). This motif is replaced by the CxxS motif in mouse and human
TGR, but conserved in TGRs from lower eukaryotes. MIR also has a C-terminal
extensionthat is2aashorterthanthat inTRsandhasaCC(twoadjacentcysteines)
motif. In addition, the majority of (but not all) known MIRs contain one or two
copies of an N-terminal metal-binding domain. This domain has the CxxC motif
but exhibits a different fold compared with Trx and Grx.
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and TR domains in TGR appeared to provide specificity for the
GSH system while conserving specificity for the Trx system.
Mammalian TR1s exhibit broad substrate specificity (due to the
presence of the highly reactive Sec) and reduce not only Trx and
DTNB (Table 1), but also various unrelated redox proteins and
compounds, including GPxs, protein disulfide isomerase, NK-lysin,
selenite, Sec, vitamin K, alloxan, and other proteins and compounds
(13). TR1s exhibit NADPH-dependent peroxidase activity and are
capable of reducing H2O2, organic hydroperoxides, and lipid hy-
droperoxides. Sec is essential for reactions catalyzed by TR1
including peroxidase activities (36–38). In TGR, the presence of the
Grx domain, in addition to the sequences highly homologous to
TR1, appeared to increase a host of activities by adding those with
specificity for the GSH system.
Biochemical Probing of TGR Structure. We used polyclonal antibod-
ies specific for the C-terminal peptide of TGR (12) to immu-
noprecipitate TGR in its reduced and oxidized states from the
testis microsomal fraction. Interestingly, TGR was most effi-
ciently precipitated when reducing agents (DTT, NADPH, or
GSH) were added to the incubation mixture, whereas the
absence of redox agents or the presence of an oxidant H2O2
inhibited the immunoprecipitation reaction (Fig. 3A). These
observations suggested that the reduction of TGR caused con-
formational changes involving the C-terminal peptide and that
this peptide was accessible for other proteins when the enzyme
was in a reduced state, but buried in the protein globule when the
enzyme was oxidized.
The antibodies specific for the C-terminal peptide also were
used to determine the location of TGR in 75Se-labeled subcel-
Fig. 3. Characterization of TGR. (A) Immunoprecipitation. Microsomal frac-
tion was incubated with purified rabbit polyclonal antibodies specific for the
C-terminal peptide of TGR in the presence of 100 mM H2O2 (lane 1), water (lane
2), 5 mM DTT (lane 3), 5 mM NADPH (lane 4), or 5 mM GSH (lane 5). TGR was
subsequently precipitated with Protein A-Sepharose, and the pellet (precipi-
tated) and supernatant (unprecipitated) fractions were analyzed by immuno-
blot assays with antibodies specific for TGR. (B) Localization in subcellular
fractions. Homogenate of 75Se-labeled mouse testes was fractionated by
differential centrifugation. Nuclear (1,000-g pellet), mitochondrial (10,000-g
pellet), microsomal (105,000-g pellet), and cytosolic (supernatant after cen-
trifugation at 105,000 g) fractions were analyzed by immunoblot assays with
antibodies specific for TGR (Upper) and by PhosphorImager analyses of 75Se on
SDSyPAGE gels (Lower). In addition to the TGR location, the location of major
75Se-labeled selenoproteins, TR1, GPx1, and GPx4, are shown on the right.
Masses of standards are shown on the left.
Table 1. Kinetic parameters for TGR catalytic activities
Substrates TR1 TGR
Specific activity
(mmolymin
per mg)
NADPH 1 DTNB (TR activity) 25 6 3.0 3.1 6 0.35
NADPH 1 Trx (TR activity) 5.9 6 0.6 4.2 6 0.6
NADPH 1 GSSG (GR activity) ND 2.0 6 0.34
NADPH 1 HED (Grx activity) ND 1.9 6 0.2
Apparent Km
(mM)
DTNB 212 14.7
NADPH 19.6 10.7
Trx 4.73 3.0
GSSG — 8.84
HED — 45.2
Apparent kcat
(min21)
DTNB 5,180 392
Trx 590 340
GSSG — 94
HED — 72
Apparent kinetic parameters were determined as described in Experimen-
tal Procedures using Lineweaver–Burk plots and varying concentrations of
one substrate (2.5–500 mM GSSG, 10–500 mM HED, 0.069–0.69 mM Trx, or
1.25–425 mM DTNB) in a corresponding two-substrate reaction, while main-
taining the concentration of a second substrate, NADPH, constant at 0.2 mM.
Likewise, NADPH parameters were determined at 2–60 mM NADPH and 5 mM
DTNB. ND, not detected.
Fig. 2. TGR exhibits affinity for GSH. (A) Binding of TGR to GSH. Purified
mouse TR1 and TGR were incubated separately with GSH-Sepharose, after
which bound and unbound (flow-through) fractions were analyzed by SDSy
PAGE analysis followed by Coomassie blue staining of TR1 (Top) or TGR
(second from Top) or subjected to immunoblot analysis with antibodies
specific to either TR1 (third from Top) or to TGR (Bottom). (B) Reduction of TGR
by GSH or NADPH. TGR or TR1 were incubated with either 100 mM NADPH or
500 mM GSH, alkylated with 20 mM 5-iodoacetamido-fluorescein (5-IAF), and
detected by immunoblot analyses with antibodies specific to TR1 (Top), to TGR
(second from Top), or to fluorescein (third from Top), or by Coomassie blue
staining of the SDSyPAGE gel (Bottom). The positions of TR1 and TGR are
shown on the right.
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lular fractions of mouse testis obtained by differential centrifu-
gation. TGR was found in the microsomal fraction (Fig. 3B), the
location that distinguished the enzyme from TR1 and Grx,
located in the cytosol (39); TR3, located in mitochondria (12,
40–43); and GR, located in both cytosolic and mitochondrial
fractions (44). To determine whether the presence of TGR in the
microsomal pellet was due to its participation in a large molec-
ular weight complex, the microsomal and cytosolic testis fraction
was subjected to chromatography on a calibrated gel-filtration
column, followed by the detection of TGR in the column
fractions by using immunoblot assays. The calculated molecular
mass of the native TGR was ’130 kDa. Thus, TGR was not a
component of a large molecular weight complex, and its exper-
imental mass was consistent with homodimer composition of the
enzyme, which is typical of pyridine nucleotide disulfide
oxidoreductases.
Molecular Modeling of TGR Structure. Although three-dimensional
structures for animal TRs are not known, structures and reaction
mechanisms have been extensively characterized for homolo-
gous pyridine nucleotide disulfide oxidoreductases. In these
enzymes, the N-terminal thiolydisulfide active center is a key
player in the reaction mechanism. During the catalysis, the
disulfide in the oxidized enzyme is reduced with electrons
provided by NADPH (via enzyme-bound FAD) and further
serves as a reductant for specific substrates. Glutaredoxins also
have been extensively characterized both structurally and mech-
anistically (1).
We modeled the pyridine nucleotide disulfide oxidoreductase
portion of the TGR homodimer (Fig. 4A) on the basis of crystal
structures of three template proteins: GR from Escherichia coli
(34.5% identity to TGR; Protein Databank code 1GES), trypano-
thione reductase from Crithidia fasciculata (34.3% identity; Protein
Databank code 1FEC) and MIR from Bacillus sp. strain RC607
(28.4% identity; atomic coordinates kindly provided by Emil Pai,
University of Toronto) (45). MIR has a C-terminal extension
containing a conserved Cys-Cys dipeptide that delivers Hg21 to the
thiolydisulfide center (46, 47). This extension is homologous to the
C-terminal extension of TGR, and the Cys-Cys dipeptide in MIR
may be considered as a functional analog of the Cys-Sec pair in TRs
(48). Hence, the MIR structure was used to build the C-terminal
extension of TGR.
The Grx domain of the TGR molecule was separately modeled
by using the NMR-derived structures of human and E. coli Grxs
Fig. 4. Molecular modeling and reaction mechanism of TGR. (A) Molecular
model of the TGR homodimer. The three-dimensional model was obtained as
described under Experimental Procedures. The pyridine nucleotide disulfide
oxidoreductase portion and the C-terminal extension (TR domain) of subunit
A are shown in green and of subunit B in red. The Grx domain of subunit A is
shown in cyan and of subunit B in purple. The location of the TR and Grx
domains and the peptide that links these domains (linker peptide) are indi-
cated for both subunits. Active centers are circled. Two FAD molecules
are shown in blue, and Cys-48, Cys-175, Cys-180, Cys-613, and Sec-614 in both
subunits are shown in yellow. (B) Molecular model of the enzyme active
center. FAD molecule is shown in blue. Cys-48, Cys-175, and Cys-180 in subunit
A and Cys-613 in subunit B are shown in yellow. Sec-614 in subunit B is shown
in red. The location of protein chains that surround the active center are
shown in the background in magenta. The Cys-613ySec-614 and Cys-175yCys-
180 pairs are shown in the oxidized state. Predicted interactions of the
Cys-613ySec-614 dipeptide with the disulfide center (Cys-175yCys-180) and the
active center of the Grx domain (Cys-48) are shown by dashed arrows. In the
initial step of catalysis by TGR, NADPH reduces FAD. The predicted direction of
electron flow in subsequent steps of catalysis (A: FAD3A: Cys-175yCys-
1803B: Cys-613ySec-6143A: Cys-48) is shown by the open arrow. (C) Reaction
mechanism of TGR. Proposed electron flow involving TGR (Upper) and, for
comparison, components of the GSH system (Lower) is shown. TGR is func-
tionally and structurally analogous to a fusion of GR, Grx, and two molecules
of GSH and supports five electron transfer events. The roles of redox groups
are as follows: the thiolydisulfide redox center initially accepts electrons from
NADPH via FAD. In the GSH system, GSSG is then directly reduced by the
thiolydisulfide center, whereas in TGR, the C-terminal tetrapeptide serves a
role of a protein-linked GSSG and is reduced by the thiolydisulfide center.
Electrons are further transferred from GSH to Grx in the GSH system or by a
conformational movement of the C-terminal tetrapeptide of TGR from the
thiolydisulfide center to the Grx domain. Finally, Grx or the Grx domain
interact with an electron acceptor (for example, GSH-mixed disulfide), com-
pleting the reaction.
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(34.4% identity, Protein Databank code 1JHB; and 36.6%
identity, Protein Databank code 3GRX, respectively). The two
modeled parts of TGR were linked by a nine-residue peptide.
Analyses of these molecular models (Fig. 4 A and B) revealed
predicted structural features that helped in characterizing the
reaction mechanism of TGR. First, the thiolydisulfide active
center in TGR was located deep in the protein globule and linked
to a protein surface through a narrow and long channel, similar
to that found in other pyridine nucleotide disulfide oxidoreduc-
tases. The thiolydisulfide center did not appear to be accessible
for protein substrates (e.g., Trx or the Grx domain) in the TGR
model. This is not surprising considering that substrates for
homologous pyridine nucleotide disulfide oxidoreductases are
small compounds (e.g., GSSG, oxidized lipoamide) whereas Trx
and the Grx domain are larger globular structures.
Second, the C-terminal peptide in the TGR model was buried
inside the oxidized enzyme with Sec being in the vicinity of the
disulfide center. This observation was consistent with our finding
that the C-terminal extension of TGR was not accessible in the
oxidized state (Fig. 3A). The structure of the C-terminal exten-
sion was analogous to the lipoamide arm that interacts with the
thiolydisulfide center of LDH within the pyruvate dehydroge-
nase multienzyme complex (21). Our model (Fig. 4B) revealed
that the C-terminal extension of TGR perfectly fits into the
channel such that the Cys-Sec motif of one subunit could interact
directly with the thiolydisulfide center of another subunit in the
TGR homodimer. Whereas the C-terminal extension of MIR is
thought to interact with the disulfide center through Hg21 (46,
47), the C-terminal extension of TGR was 2 aa longer and could
make a direct contact with the thiolydisulfide active center.
Third, the predicted binding site for the Grx domain was
formed by both subunits of the TGR homodimer (Trx presum-
ably binds in the same place) (Fig. 4A). The nine-residue linker
peptide between the Grx domain and the major portion of TGR
may ensure the access of Trx in place of the Grx domain. The
pullout mechanism for the release of the C-terminal extension
from the channel after its reduction by the thiolydisulfide center
appeared unlikely. In contrast, the C-terminal extension could
reach the surface of the TGR model by a pendulum-like
movement within the channel such that the Cys-Sec motif could
directly interact with the active site Cys of the Grx domain (Fig.
4B) or be accessible for other targets (e.g., Trx) and such that the
C-terminal extension could become accessible for antibodies
specific for the C-terminal peptide.
Reaction Mechanism of TGR. The organization of the TGR ho-
modimer model (Fig. 4A) was such that the Cys-Sec motif of one
subunit could transfer electrons from the thiolydisulfide center to
the Grx domain of the second subunit and vice versa. The con-
served C-terminal Gly-Cys-Sec-Gly motif may be considered as an
analog of small disulfide substrates (e.g., GSSG for GR or lipoate
for LDH), which is linked to a pyridine nucleotide disulfide
oxidoreductase portion of the protein. In other words, TGR may be
viewed as a fusion of three components, which correspond to Grx,
GR, and GSSG in the GSH system (Figs. 1B and 4C).
These observations suggested a mechanism whereby electrons
were transferred from NADPH to downstream electron donors
through several redox centers within TGR, NADPH3 FAD3
thiolydisulfide center 3 the C-terminal GSSG-like Sec-
containing center 3 the Cys residue within the Grx domain 3
downstream substrate (Fig. 4 B and C). The key component in
this remarkable electron flow was the Gly-Cys-Sec-Gly tetrapep-
tide that transfers electrons between redox centers through
reversible oxidoreduction coupled with conformational changes.
The proposed mechanism is consistent with previous models
(9, 20, 22, 23, 34), which proposed, on the basis of kinetics,
site-specific mutations and protein microchemistry studies, that
the C-terminal redox motif in mammalian TR1 and TR from
Plasmodium falciparum can be directly reduced by the N-
terminal thiolydisulfide center. Similarity is also evident to LDH,
whose substrate, lipoic acid, contains an internal disulfide that
transfers electrons and substrate molecules among three differ-
ent active centers located within three polypeptides (21). Lipoic
acid is fused to a protein component of the pyruvate dehydro-
genase complex via a long hydrophobic arm that delivers this
compound to various reaction centers.
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